Ann: Change in substantial holding, page-8

First 8 Last

Share
Profile

Follow
ohisay

44 Posts.

2

04/01/24

13:31

Post #: 71724691
Share

Originally posted by pds1961: ↑

CP, anything is possible with this speculative stock.

Biotechs have taken a beating in the past 2 years, however some recent early signs of a slight turn around.

The fact that institutional investors have put in $10M is encouraging. They wouldn’t invest with eyes closed and one would anticipate they have done due diligence. Who knows whether they are truly long term, or a chance to make a profit in the short term. The potential of good news from clinical trials is genuine. Perhaps they have confidentiality clauses as part of their investment deal and have a greater appreciation (direct knowledge) of the strength of what the company is doing.

If you look at other recent biotech CRS like IMU and CHM, the SP took a battering falling below the SPP offered, but since recovered. Was that deliberate strategy from the big end of town to shake shares from retail investors and accumulate? Likely for both of those examples, especially IMU.

I’ll be holding off until closer to the closing date. If the SP is below the SPP I’ll take the cheaper option.

I will only invest what I’m prepared to lose, or an amount that I don’t need in the near future.

PDS

Expand

Its disappointing of course to see the share price here .
And I wont applaud the issuing of zero cost options by the BOD to Gary et al .

But a bit of perspective is in order here .
I thought this summary from * last year covered SNT quite well ..

https://**promotion blocked**/experts/dr-borehams-crucible-investors-have-been-holding-their-breath-for-pharmaxis-rebirth-time-to-exhale/

SNT Price at posting: 1.9¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 8 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.1¢		Change -0.002(3.77%)		Mkt cap ! $81.24M

Open	High	Low	Value	Volume
5.2¢	5.3¢	4.9¢	$145.4K	2.870M

Buyers (Bids)

No.	Vol.	Price($)
4	436329	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.0¢	250	1

View Market Depth

No.	Vol.	Price($)
4	436329	0.049
5	301833	0.048
2	210276	0.047
3	950000	0.046
9	1504898	0.045

Price($)	Vol.	No.
0.050	250	1
0.051	558010	7
0.052	97290	3
0.053	369974	1
0.054	500762	3

Last trade - 11.51am 26/06/2025 (20 minute delay)

SNT (ASX) Chart

Ann: Change in substantial holding, page-8

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Change in substantial holding, page-8

Top Stories

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News